Plasma prostaglandins and the renin-aldosterone system in patients with labile or permanent essential hypertension
Hornych, A.; London, G.; Safar, M.; Weiss, Y.; Simon, A.; Guyene, T.T.; Bariéty, J.; Milliez, P.
Journal d'Urologie et de Nephrologie 84(12): 843-849
1978
ISSN/ISBN: 0021-8200 PMID: 748572 Document Number: 132741
Document emailed within 1 workday
Related Documents
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941Kida, O.; Kodama, K.; Higa, T.; Someya, N.; Kondo, K.; Morotomi, Y.; Tanaka, K. 1984: Effects of captopril on renin-angiotensin-aldosterone system and kallikrein-kinin system in patients with essential hypertension Nihon Jinzo Gakkai Shi 26(11): 1487-1493
Fievet, P.; Gregoire, I.; Agnes, E.; Herve, M.A.; Carayon, A.; Mimram, A.; Boulanger, J.C.; Fournier, A. 1986: Renin-angiotension-aldosterone system, urinary prostaglandins and kallikrein in pregnancy-induced hypertension: evidence for a dysregulation of the renin-angiotensin-prostacyclin loop Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 4(5): S88-S91
Wnuk, R.; Kokot, F. 1991: Effect of nifedipine treatment on the renin-aldosterone system and secretion of cortisol and growth hormone in patients with essential hypertension Endokrynologia Polska 42(3): 421-427
Januszewicz, W.; Wocial, B.; Ignatowska-Switalska, H.; Sznajderman, M.; Feltynowski, T.; Grzesiuk, W. 1982: Effect of prazosin on catecholamines, renin-aldosterone system and prostaglandins in primary hypertension Polski Tygodnik Lekarski 37(18): 515-518
Cugini, P.; Serdoz, R.; Manconi, R.; Mancini, A.; Meucci, T. 1978: Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension Bollettino della Societa Italiana di Biologia Sperimentale 54(2): 111-115
Zelnick, N.; Boner, G.; Rosenfeld, J. 1982: The renin-aldosterone system in the diagnosis of essential hypertension Harefuah 102(4): 139-141
García Zozaya, J.L.; Padilla Viloria, M. 1997: Alterations of calcium, magnesium, and zinc in essential hypertension:their relation to the renin-angiotensin-aldosterone system Investigacion Clinica 38(Suppl 2): 27-40
Cerasola, G.; Cottone, S.; Mangano, M.T.; D'Ignoto, G.; Pinto, A.; Carone, M.B. 1988: Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension Clinical Therapeutics 10(6): 694-703
Kiknadze, M.P. 1992: The characteristics of the changes in the renin-aldosterone system, prostaglandins and cyclic nucleotides of patients with a fatal outcome against a background of chronic heart failure Terapevticheskii Arkhiv 64(12): 35-36
Ershova, G.S. 1984: The renin-angiotensin-aldosterone system in patients with stage-Ii hypertension Vrachebnoe Delo 2: 58-61
Nowicki, M.; Kokot, F.; Wiecek, A. 1993: Relation between erythropoietin production and plasma renin activity in patients with essential hypertension Kardiologia Polska 39(7): 17-22
Pirrelli, A.; Pieri, R.; Dolce, E. 1976: Correlations between plasmatic renin and aldosterone in essential arterial hypertension with sympathetic hyperactivity Bollettino Della Societa Italiana di Cardiologia 21(3): 511-515
Collart, F.; Staroukine, M.; Verniory, A. 1985: Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension Acta Cardiologica 40(3): 269-276
Wieçek, A.; Kokot, F. 1985: Behavior of the renin-angiotensin-aldosterone system and vasopressin secretion in patients with renovascular hypertension or small kidney Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(6): 172-176
Leviashvili, B.I. 1988: Hemodynamic indices and the renin and aldosterone levels of the blood plasma in patients with different forms of arterial hypertension undergoing combined kristepin and propranolol treatment Kardiologiia 28(1): 81-82
He, Y.-b.; Yu, X.; Zhou, X.-r.; Shu, B.-h.; Liu, J.-h. 2013: Analysis of characteristics of renin, aldosterone and aldosterone/renin ratio in patients with aldosterone-producing adenoma Zhonghua Yi Xue Za Zhi 93(42): 3379-3383
Li, Y.; Wang, L.; Xue, Z. 1995: The significance of changes in plasma renin angiotensin aldosterone system and atrial natriuretic factor in patients with high altitude myocardial hypoxidosis Zhonghua Nei Ke Za Zhi 34(12): 812-815
Ocón, J.; Piña, C.; Castellet, R.; Vila, R.; del Río, G.; Arnau, C. 1985: Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids Medicina Clinica 85(2): 53-57
Gordon, R.D.; Gomez-Sanchez, C.E.; Hamlet, S.M.; Tunny, T.J.; Klemm, S.A. 1987: Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 5(5): S103-S106